Combination Therapy with Rituximab and Temozolomide for Recurrent and Refractory Primary Central Nervous System Lymphoma

High-dose methotrexate-based chemotherapy has extended survival in patients with primary central nervous system lymphoma (PCNSL). However, although salvage treatment is necessary in recurrent and refractory PCNSL, this has not been standardized. We herein describe the efficacy of a combination of ri...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Murakami, Mineko, Fujimaki, Takamitsu, Asano, Shuichiro, Nakaguchi, Hiroshi, Yamada, Shoko M., Hoya, Katsumi, Yamazaki, Kazuto, Ishida, Yasuo, Matsuno, Akira
Format: Artigo
Jezik:Inglês
Izdano: Yonsei University College of Medicine 2011
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3220260/
https://ncbi.nlm.nih.gov/pubmed/22028172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2011.52.6.1031
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki